Companies: 10,795·Total market cap: $144.5T
Novartis AG

Novartis AG

NVSEFOTCHealthcare● Active
$148.80
+$4.66(+3.23%)
Market Cap$283.9B
P/E Ratio
52W High$171.29
52W Low$110.74
Overview

Novartis AG(NVSEF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NVSEF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$57.13B$51.72B$46.66B$51.83B$52.88B
Cost of Revenue$14.27B$12.83B$12.02B$15.49B$15.87B
Gross Profit$42.86B$38.90B$34.64B$36.34B$37.01B
Gross Margin %(computed)75.02%75.20%74.24%70.12%69.99%
Operating Expenses
R&D Expenses$11.20B$10.02B$11.37B$10.00B$9.54B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$25.06B$24.35B$24.87B$27.14B$25.32B
Operating Income$17.80B$14.54B$9.77B$9.20B$11.69B
Operating Margin %(computed)31.15%28.12%20.94%17.75%22.11%
Interest Income$0.39B$0.55B$0.44B$0.39B$0.07B
Interest Expense$1.24B$1.01B$0.85B$0.86B$0.91B
Income Before Tax$17.13B$13.64B$9.12B$8.37B$25.02B
Income Tax Expense$2.50B$1.70B$0.55B$1.42B$2.12B
Net Income$14.65B$11.94B$14.85B$6.96B$24.02B
Net Margin %(computed)25.64%23.09%31.83%13.42%45.43%
Per Share & EBITDA
EPS (Basic)$7.56$5.92$7.63$3.29$10.73
Wtd Avg Shares1.94B2.02B2.08B2.18B2.24B
EBITDA$23.96B$20.71B$19.52B$15.21B$17.17B
EBITDA Margin %(computed)41.94%40.05%41.83%29.35%32.47%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Novartis AG

关于Novartis AG(NVSEF)损益表

Novartis AG(NVSEF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NVSEF实现营收$57.13B,毛利润$42.86B(毛利率75.02%),净利润$14.65B(净利率25.64%)。

常见问题

NVSEF · 4 问

Novartis AG(NVSEF)2025财年营收为$57.13B,同比up10.4%。

NVSEF revenueNVSEF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08